Nilanjan Ghosh, MD | Authors


Exploring Unmet Needs and BTK Inhibitors in the MCL Population

August 20, 2020

Nilanjan Ghosh, MD, discusses the current unmet needs in mantle cell lymphoma and how Bruton’s tyrosine kinase inhibitors are being looked at to fill that need for patients with high-risk disease in the first line.

Exploring Updated Data for Large B-Cell Non-Hodgkin Lymphoma

August 05, 2020

Nilanjan Ghosh, MD, discusses the significance of the data from a pilot study of lisocabtagene maraleucel in patients ineligible for second-line transplant with relapsed/refractory aggressive large B-cell non-Hodgkin lymphoma.